COVID-19 in Three Patients with Pemphigus.

Bendaoud, Layla; Elfaqyr, Iyda; Hocar, Ouafa; Amal, Said

Bendaoud, Layla; Elfaqyr, Iyda; Hocar, Ouafa; Amal, Said.

Bendaoud L; Department of Dermatology, Faculty of Medicine and Pharmacy, Mohammed VI University Hospital, Cadi Ayyad University, Marrakech, Morocco; laylabendaoud@gmail.com.
Elfaqyr I; Department of Dermatology, Faculty of Medicine and Pharmacy, Mohammed VI University Hospital, Cadi Ayyad University, Marrakech, Morocco.
Hocar O; Department of Dermatology, Faculty of Medicine and Pharmacy, Mohammed VI University Hospital, Cadi Ayyad University, Marrakech, Morocco.
Amal S; Department of Dermatology, Faculty of Medicine and Pharmacy, Mohammed VI University Hospital, Cadi Ayyad University, Marrakech, Morocco.

Skinmed ; 20(6): 428-429, 2022.

Article in English | MEDLINE | ID: covidwho-2167707

ABSTRACT

ABSTRACT

COVID-19 is an infectious disease caused by the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). It has various clinical presentations, ranging from mild and moderate to severe manifestations. This infection has caused disruptions worldwide, particularly for healthcare professionals, regarding the prescribing of immunosuppressive drugs for chronic autoinflammatory and autoimmune pathologies, such as pemphigus. We report three pemphigus patients who being treated with immunosuppressive therapy developed the SARS-CoV-2 infection. (SKINmed. 2022;20428-429).

Subject(s)

COVID-19; Pemphigus; Humans; SARS-CoV-2

Search on Google

XML

PubMed Links

Collection: International databases Database: MEDLINE Main subject: Pemphigus / COVID-19 Type of study: Case report / Prognostic study Limits: Humans Language: English Journal: Skinmed Journal subject: Dermatology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

PubMed Links